← Back
Data updated: Mar 10, 2026
ANACOR PHARMS INC
OncologyDermatologyInfectious Disease
ANACOR PHARMS INC is a pharmaceutical company focused on Oncology, Dermatology, Infectious Disease. Key products include EUCRISA.
2014
Since
2
Drugs
-
Trials
0
Approved (2yr)
Recent Activity
No recent activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 42%
0 drugs Phase 3: 3 Phase 1: 2
Dermatology 33%
1 drugs Phase 3: 1 Phase 1: 1
Infectious Disease 24%
0 drugs Phase 3: 1 Phase 2: 2
Pipeline Strength Pro
Loading...
Competitors Pro
Pfizer big-pharma
Oncology, Infectious Disease, Dermatology
Baxter specialty
Infectious Disease, Oncology, Dermatology
COSETTE other
Dermatology, Infectious Disease, Oncology
KING PHARMS LLC big-pharma
Infectious Disease, Dermatology, Oncology
FOUGERA PHARMS other
Dermatology, Infectious Disease, Oncology